News

Data-driven processes are essential for any firm, yet even the largest enterprises struggle to extract useful information from data sources dispersed across multiple applications and teams. This leaves many functions unable to make objective, business-critical decisions, instead operating on opinions and whims.

Business Information as exists today typically requires big, bespoke data warehouse projects, building rigid data models to integrate several separate data tools. This approach is time-consuming, complex, costly and inflexible.

Spinout marks the first of UCLTF’s early stage investments to file for IPO.

Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, has today announced closing of its initial public offering of 16,103,572 American Depositary Shares (“ADSs”), each representing an ordinary share at an initial public offering price of $14.00 per share. The gross proceeds from the offering were $225.5 million before deducting underwriting commissions and estimated…

Global private equity firm specialising in high-growth companies invests in Egress to accelerate global expansion.

Egress, a leading provider of data privacy and compliance services designed to secure unstructured data, today announced it has raised $40 million in a Series C financing round from FTV Capital, with continued participation from existing backer AlbionVC. Egress will use this investment to build on its ongoing rapid growth in Europe and North America, as well as accelerate development of new technology across its data security…

AlbionVC and Ananda Ventures have led a £3m fundraising round in Raremark, the leading patient-data platform in rare disease. Oltre Venture and, existing major investor, the Cass Entrepreneurship Fund also invested. 

The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments.

Raremark’s platform is the foundation for building research networks of rare disease patients and…

Hazy has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch. Hazy is an AI spin-out from UCL and is one of the businesses invested in by the UCL Technology Fund which is managed by Albion in collaboration with UCLB.

www.forbes.com/15-machine-learning-companies-to-watch-in-europe

Albion is delighted to have been awarded the Investor Allstars 2018  - VCT of The Year Award.

•The judges looked for a track record of fundraising between April 2017 – April 2018 • An impressive level of investment and exits achieved during the period • A reputation for providing valuable strategic and commercial advice to portfolio companies • A strong financial return for private investors

 

Arecor, the UK-based biopharmaceutical formulation company, has raised £6 million from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes. The fundraising was led by Calculus Capital, Albion Capital, and Downing Ventures.  BioScience Managers Limited, the international healthcare investment firm, advised Downing Ventures.Through the application of its technology platform, Arecor is creating faster working, more effective drugs that help progress the creation of the next generation of…

Forward Health, the app working to reinvent healthcare communication, has today announced a $3.9M seed funding-round led by Stride.VC , with additional backing from AlbionVC . The funds are joined by an impressive roster of angel backers, including healthtech founders Jay Desai from US company Patient Ping and Melissa Morris from UK-based Lantum .

Forward was founded in 2016 by UK doctors Barney Gilbert and Lydia Yarlott, alongside serial entrepreneur Philip Mundy. Their mission is to connect healthcare systems around the world, making…